STAT6 mutations are enriched at relapse in DLBCL and localize to the D419 hotspot within the DNA-binding domain [9], implying that mutations in the STAT6D419 DNA-binding domain are functionally significant in rrDLBCL. The gene discussed is STAT6; the disease is diffuse large B-cell lymphoma.